000 | 01821 a2200553 4500 | ||
---|---|---|---|
005 | 20250517135933.0 | ||
264 | 0 | _c20170807 | |
008 | 201708s 0 0 eng d | ||
022 | _a1527-3350 | ||
024 | 7 |
_a10.1002/hep.28961 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCadier, Benjamin | |
245 | 0 | 0 |
_aEarly detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _c04 2017 |
||
300 |
_a1237-1248 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xeconomics |
650 | 0 | 4 |
_aCatheter Ablation _xeconomics |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCost-Benefit Analysis _xmethods |
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aEarly Detection of Cancer _xeconomics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFrance |
650 | 0 | 4 |
_aHepatectomy _xeconomics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Neoplasms _xeconomics |
650 | 0 | 4 |
_aLiver Transplantation _xeconomics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMarkov Chains |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aBulsei, Julie | |
700 | 1 | _aNahon, Pierre | |
700 | 1 | _aSeror, Olivier | |
700 | 1 | _aLaurent, Alexis | |
700 | 1 | _aRosa, Isabelle | |
700 | 1 | _aLayese, Richard | |
700 | 1 | _aCostentin, Charlotte | |
700 | 1 | _aCagnot, Carole | |
700 | 1 | _aDurand-Zaleski, Isabelle | |
700 | 1 | _aChevreul, Karine | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 65 _gno. 4 _gp. 1237-1248 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.28961 _zAvailable from publisher's website |
999 |
_c26860742 _d26860742 |